Rupatadine
Rupatadine, the active substance of Rupaxa, has antihistamine properties.
Rupaxa relieves the symptoms of allergic rhinitis, such as sneezing, runny nose, itchy eyes and nose.
Rupaxa is also used to relieve the symptoms of urticaria (allergic skin rash), such as itching and hives (local redness and swelling of the skin).
Rupaxa is intended for use in adults and adolescents (12 years and older).
Before taking Rupaxa, discuss it with your doctor or pharmacist.
If you have kidney or liver problems, consult your doctor. Rupaxa is not recommended for patients with kidney or liver disorders.
In case of low potassium levels in the blood and/or abnormal heart rhythm (known as QTc interval prolongation in the ECG), which may occur in some heart diseases, consult your doctor.
If you are over 65 years old, you should consult your doctor or pharmacist.
Rupaxa should not be taken by children under 12 years of age.
Tell your doctor or pharmacist about all the medicines you are taking, or have recently taken, and about any medicines you plan to take, including those obtained without a prescription.
If you are taking Rupaxa, you should not take medicines containing ketoconazole (a medicine used to treat fungal infections) or erythromycin (a medicine used to treat bacterial infections).
If you are taking medicines that affect the central nervous system or statins (medicines used to treat high cholesterol), or midazolam (a short-acting sedative and anxiolytic), you should consult your doctor before taking Rupaxa.
Rupaxa at the recommended dose (10 mg) does not increase drowsiness caused by alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medicine.
Rupaxa should not be taken during pregnancy and breastfeeding, unless clearly indicated by your doctor.
Before taking any medicine, consult your doctor or pharmacist.
Rupaxa, taken at the recommended dose, should not affect your ability to drive or operate machines. However, if you are taking Rupaxa for the first time, you should be cautious and observe your reaction to the medicine.
If you have been told that you have an intolerance to some sugars, you should consult your doctor before taking this medicine.
This medicine should always be taken exactly as directed by your doctor. If you are unsure, consult your doctor or pharmacist.
Rupaxa is intended for use in adolescents (12 years and older) and adults.
The usual dose is one tablet (10 mg rupatadine) once daily, with or without food. The tablet should be swallowed with a sufficient amount of liquid (e.g., a glass of water).
Your doctor will inform you how long the treatment with Rupaxa will last.
If you have accidentally taken a large dose of the medicine, you should immediately consult your doctor or pharmacist.
Take the missed dose as soon as possible, and then continue taking the tablets as directed.
Do not take a double dose to make up for the missed dose.
Like all medicines, Rupaxa can cause side effects, although not everybody gets them.
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date (EXP) stated on the blister and carton.
The expiry date refers to the last day of the month.
There are no special storage instructions for this medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Rupaxa is a round, light orange tablet with a diameter of 6.35 mm, packaged in blisters contained in packs of 15, 20, 30, 50, or 100 tablets.
Not all pack sizes may be marketed.
Biofarm Sp. z o.o.
ul. Wałbrzyska 13
60-198 Poznań
MEIJI PHARMA SPAIN S.A
Avda de Madrid, 94
28802 Alcala de Henares, Madrid
Spain
MARTIN DOW PHARMACEUTICALS
Goualle Le Puy, Champ de Lachaud
19250 Meymac
France
Poland:
Rupaxa
Date of last revision of the leaflet:04.08.2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.